Superwarfarins represent a class of long‐acting anticoagulant rodenticides that exert their effect through profound inhibition of vitamin K recycling, primarily by targeting vitamin K epoxide ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

Blood has many functions and circulates throughout your body. As a result, problems with it can affect you in many ways. Some of those problems can stem from a blood disorder. These disorders can ...

Research led by Randal J. Kaufman, Ph.D., has found that misfolded proteins in liver cells contribute to the development of liver cancer, shedding new light on the mysterious origins of one of the ...

The product identifies variations in three genes that increase a person’s risk. Nanosphere received FDA clearance for its second molecular diagnostic assay that predicts a person’s risk of developing ...

Blood disorders affect millions of people worldwide, yet their potential to develop into blood cancers often goes unrecognized. Medical experts emphasize that understanding this connection plays a ...

CHAPEL HILL -- New research at the University of North Carolina at Chapel Hill has found that a fatty molecule on the surface of platelet cells is a regulator of blood coagulation. Besides its role in ...

Like its namesake star twinkling 25 light-years from Earth, Vega Therapeutics hopes to shine as brightly in treating rare blood disorders, starting with a therapy for von Willebrand disease (VWD) that ...

Red blood cell disorders refer to conditions that affect either the number or function of red blood cells (RBCs). Also known as erythrocytes, RBCs are concave, disc-shaped cells that move through ...

Space travel alters hemoglobin gene expression, increasing fetal globin production and shifting erythropoiesis to a primitive type. Low gravity in space increases the risk of coagulation disorders, ...

FRANKFURT/PARIS (Reuters) - Europe's medicines watchdog concluded on Thursday that AstraZeneca's coronavirus vaccine still far outweighed any risks after investigating reports of rare blood clotting ...